Covestor LTD Bio N Tech Se Transaction History

Covestor LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$80.36 - $102.87 $1,928 - $2,468	-24 Reduced 5.78%	391 $31,000
Q1 2024 May 10, 2024	BUY	$88.96 - $112.35 $11,831 - $14,942	133 Added 47.16%	415 $38,000
Q4 2023 Feb 09, 2024	SELL	$90.91 - $112.75 $909 - $1,127	-10 Reduced 3.42%	282 $30,000
Q3 2023 Nov 13, 2023	BUY	$98.5 - $125.08 $28,762 - $36,523	292 New	292 $32,000
Q4 2022 Feb 13, 2023	BUY	$118.43 - $186.05 $0 - $0	0 New	0 $0
Q4 2022 Feb 13, 2023	BUY	$118.43 - $186.05 $0 - $0	0 New	0 $0
Q3 2022 Nov 14, 2022	BUY	$127.65 - $183.11 $0 - $0	0 New	0 $0
Q2 2022 Aug 10, 2022	BUY	$123.25 - $186.24 $0 - $0	0 New	0 $0
Q1 2022 May 13, 2022	SELL	$126.25 - $231.85 $22,977 - $42,196	-182 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$216.64 - $362.52 $39,428 - $65,978	182 New	182 $47,000

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

Stay updated on Covestor LTD with notifications on news.